Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246

1991 ◽  
Vol 27 (3) ◽  
pp. 390-392 ◽  
Author(s):  
R. N. JONES ◽  
J. A. WASHINGTON ◽  
M. A. PFALLER ◽  
F. P. KOONTZ ◽  
E. H. GERLACH ◽  
...  
1991 ◽  
Vol 14 (6) ◽  
pp. 485-493 ◽  
Author(s):  
Gary V. Doern ◽  
E.Hugh Gerlach ◽  
James H. Jorgensen ◽  
Patrick R. Murray ◽  
Clyde Thornsberry ◽  
...  

1992 ◽  
Vol 15 (2) ◽  
pp. 145-150 ◽  
Author(s):  
Michael A. Pfaller ◽  
Ronald N. Jones ◽  
John A. Washington ◽  
Franklin P. Koontz ◽  
E. Hugh Gerlach ◽  
...  

2001 ◽  
Vol 7 (2) ◽  
pp. 93-95
Author(s):  
P.C. Fuchs ◽  
A.L. Barry ◽  
S.D. Brown ◽  
M.M. Traczeski

1999 ◽  
Vol 43 (2) ◽  
pp. 283-286 ◽  
Author(s):  
D. L. Butler ◽  
C. J. Jakielaszek ◽  
L. A. Miller ◽  
J. A. Poupard

ABSTRACT Current National Committee for Clinical Laboratory Standards (NCCLS) susceptibility guidelines for quality control testing withHaemophilus influenzae do not include a β-lactamase-producing strain that could detect the deterioration of the β-lactamase inhibitor components of amoxicillin-clavulanic acid, ampicillin-sulbactam, and piperacillin-tazobactam. The objective of the study was to determine if comparable quality control results forEscherichia coli ATCC 35218, a β-lactamase-producing strain, would be produced for the three β-lactam–β-lactamase inhibitor agents with Haemophilus test medium and Mueller-Hinton medium. The criteria used in this study to determine if Haemophilus test medium was acceptable for quality control testing of E. coli ATCC 35218 was that 100% of the results obtained with an antimicrobial agent-methodology combination needed to be within the acceptable NCCLS ranges established with Mueller-Hinton medium. The MIC testing results obtained by the broth microdilution and E-test methods with amoxicillin-clavulanic acid and piperacillin-tazobactam were all within the NCCLS ranges; however, the results obtained with ampicillin-sulbactam by both methods were not within the NCCLS ranges. Acceptable results were obtained by the disk diffusion methodology with ampicillin-sulbactam and piperacillin-tazobactam but not with amoxicillin-clavulanic acid. When performing susceptibility testing with H. influenzae with the β-lactam–β-lactamase inhibitors, in addition to quality control testing with H. influenzae ATCC 49247, testing of E. coli ATCC 35218 on Haemophilus test medium is an effective way to monitor the β-lactamase inhibitors in some antimicrobial agent-methodology combinations.


1987 ◽  
Vol 7 (1) ◽  
pp. 83-87 ◽  
Author(s):  
Arthur L. Barry ◽  
Thomas L. Gavan ◽  
Ronald N. Jones ◽  
Leona W. Ayers ◽  
Peter C. Fuchs ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document